Influence of hepatocyte growth factor, epidermal growth factor, and mycophenolic acid on endothelin‐1 synthesis in human endothelial cells
Authors:
- Cornelia HaugCHCornelia Haug
- Alexandra Schmid‐KotsasASAlexandra Schmid‐Kotsas
- Theresia LinderTLTheresia Linder
- Max G. BachemMBMax G. Bachem
- Adolf GruenertAGAdolf Gruenert
- Eva RozdzinskiEREva Rozdzinski
Open Access
- 1 December 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 16 (12) , 2310-2316
Abstract
Background. Endothelin‐1 (ET‐1) is a potent vasoconstrictive peptide which plays an important pathophysiological role in ischaemic renal failure and drug‐induced renal injury such as cyclosporin A (CsA)‐ and tacrolimus‐associated nephrotoxicity. In contrast, hepatocyte growth factor (HGF) and epidermal growth factor (EGF) seem to accelerate renal regeneration after ischaemic and drug‐induced renal injury. This study aimed to investigate the influence of HGF and EGF on ET‐1 synthesis in cultured human umbilical vein endothelial cells (HUVEC) and renal artery endothelial cells (RAEC). In addition, we have investigated whether mycophenolic acid (MPA), a new immunosuppressive drug, which in contrast to CsA and tacrolimus lacks nephrotoxic side effects, modulates ET‐1 synthesis in endothelial cells. Methods. ET‐1 release was measured with a specific enzyme‐linked immunosorbent assay. ET‐1 mRNA expression was investigated by reverse transcription polymerase chain reaction. Results. HGF and EGF (0.001−10 nM) exerted a significant concentration‐dependent inhibitory effect on ET‐1 release by HUVEC and RAEC (minimum 56.1±4.3% of control, n=6, mean±SE). The suppressive effect of HGF and EGF on ET‐1 synthesis was dose‐dependently antagonized by the tyrosine kinase inhibitors tyrphostin AG1478, lavendustin A and methyl 2,5‐dihydroxycinnamate. Incubation of HUVEC and RAEC with MPA (2.5, 10, 25, and 50 μg/ml) for 3–5 h induced a significant reduction of ET‐1 mRNA expression. After 48 h incubation with MPA (1–50 μg/ml) a significant decrease of ET‐1 release and DNA content per culture well was observed, whereas ET‐1 release referred to the DNA content in the corresponding culture well did not differ significantly from controls. Conclusions. The present findings demonstrate that HGF and EGF reduce ET‐1 synthesis in endothelial cells via their receptor tyrosine kinase activity and suggest that the renoprotective effects of HGF and EGF might be linked to their inhibitory action on ET‐1 synthesis. This study also provides evidence that, in contrast to CsA and tacrolimus, MPA does not stimulate ET‐1 synthesis. This might explain the clinical observation that renal function often improves when CsA or tacrolimus is replaced by mycophenolate mofetil.Keywords
This publication has 40 references indexed in Scilit:
- IMPROVEMENT OF IMPAIRED RENAL FUNCTION IN HEART TRANSPLANT RECIPIENTS TREATED WITH MYCOPHENOLATE MOFETIL AND LOW-DOSE CYCLOSPORINETransplantation, 2000
- Inhibitory Effect of Epidermal Growth Factor and Hepatocyte Growth Factor on Endothelin-1 Release by Rabbit Proximal Tubule CellsJournal of Cardiovascular Pharmacology, 2000
- MYCOPHENOLATE MOFETIL MONOTHERAPY IN STABLE LIVER TRANSPLANT PATIENTS WITH CYCLOSPORINE-INDUCED RENAL IMPAIRMENTTransplantation, 1999
- Endothelin up-regulation and localization following renal ischemia and reperfusionKidney International, 1999
- MYCOPHENOLATE MOFETIL-BASED, CYCLOSPORINE-FREE INDUCTION AND MAINTENANCE IMMUNOSUPPRESSIONTransplantation, 1998
- MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANT RECIPIENTS WITH CYCLOSPORINE-ASSOCIATED NEPHROTOXICITYTransplantation, 1998
- Reversal of postischemic acute renal failure with a selective endothelinA receptor antagonist in the rat.Journal of Clinical Investigation, 1994
- Inhibition of epidermal growth factor‐induced DNA synthesis by tyrosine kinase inhibitorsFEBS Letters, 1990
- Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium‐derived vasoconstrictor peptide, endothelin: Identity of human and porcine endothelinFEBS Letters, 1988
- RECEPTORS FOR EPIDERMAL GROWTH FACTOR AND OTHER POLYPEPTIDE MITOGENSAnnual Review of Biochemistry, 1987